14-day Premium Trial Subscription Try For FreeTry Free
$13.16
-0.400 (-2.95%)
At Close: May 03, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile
Date Action Amount Person Type
Apr 08, 2024 Buy 2 600 Kim Peter S Common Stock
Mar 28, 2024 Buy 1 512 Kim Peter S Common Stock
Mar 26, 2024 Buy 2 750 Kim Peter S Common Stock
Mar 25, 2024 Buy 3 180 Kim Peter S Common Stock
Mar 22, 2024 Buy 3 118 Kim Peter S Common Stock
Mar 21, 2024 Buy 704 Kim Peter S Common Stock
Mar 20, 2024 Buy 1 128 Kim Peter S Common Stock
Mar 19, 2024 Buy 900 Kim Peter S Common Stock
Mar 15, 2024 Buy 9 000 Wentworth Kory James Common Stock
Mar 15, 2024 Sell 9 000 Wentworth Kory James Stock Option (Right to Buy)
Mar 06, 2024 Sell 4 086 Wentworth Kory James Common Stock
Mar 06, 2024 Sell 1 826 Dowden Nathan J Common Stock
Mar 05, 2024 Sell 5 049 Doshi Dipal Common Stock
Mar 05, 2024 Sell 1 471 Wentworth Kory James Common Stock
Mar 05, 2024 Sell 1 486 Dowden Nathan J Common Stock
Mar 05, 2024 Sell 1 505 Sethuraman Natarajan Common Stock
Mar 04, 2024 Sell 1 164 Doshi Dipal Common Stock
Mar 04, 2024 Sell 1 391 Doshi Dipal Common Stock
Mar 04, 2024 Sell 339 Wentworth Kory James Common Stock
Mar 04, 2024 Sell 405 Wentworth Kory James Common Stock
Mar 04, 2024 Sell 343 Dowden Nathan J Common Stock
Mar 04, 2024 Sell 409 Dowden Nathan J Common Stock
Mar 04, 2024 Sell 347 Sethuraman Natarajan Common Stock
Mar 04, 2024 Sell 414 Sethuraman Natarajan Common Stock
Mar 01, 2024 Buy 104 700 Doshi Dipal Common Stock
Mar 01, 2024 Buy 158 500 Doshi Dipal Stock Option (Right to Buy)
Mar 01, 2024 Buy 30 900 Wentworth Kory James Common Stock
Mar 01, 2024 Buy 46 800 Wentworth Kory James Stock Option (Right to Buy)
Mar 01, 2024 Buy 60 000 Dowden Nathan J Common Stock
Mar 01, 2024 Buy 33 100 Dowden Nathan J Common Stock
Mar 01, 2024 Buy 50 100 Dowden Nathan J Stock Option (Right to Buy)
Mar 01, 2024 Buy 44 100 Sethuraman Natarajan Common Stock
Mar 01, 2024 Buy 66 800 Sethuraman Natarajan Stock Option (Right to Buy)
Feb 15, 2024 Sell 1 000 Doshi Dipal Common Stock
Jan 16, 2024 Sell 1 000 Doshi Dipal Common Stock
Dec 26, 2023 Sell 94 Wentworth Kory James Stock Option (Right to Buy)
Dec 26, 2023 Buy 94 Wentworth Kory James Common Stock
Dec 26, 2023 Sell 94 Wentworth Kory James Common Stock
Dec 22, 2023 Buy 10 206 Wentworth Kory James Common Stock
Dec 22, 2023 Sell 6 529 Wentworth Kory James Common Stock
Dec 22, 2023 Sell 10 206 Wentworth Kory James Stock Option (Right to Buy)
Dec 22, 2023 Sell 3 677 Wentworth Kory James Common Stock
Dec 21, 2023 Sell 2 200 Wentworth Kory James Stock Option (Right to Buy)
Dec 21, 2023 Buy 2 200 Wentworth Kory James Common Stock
Dec 21, 2023 Sell 2 200 Wentworth Kory James Common Stock
Dec 20, 2023 Sell 1 000 Doshi Dipal Common Stock
Nov 13, 2023 Sell 1 000 Doshi Dipal Common Stock
Oct 17, 2023 Sell 1 000 Doshi Dipal Common Stock
Sep 13, 2023 Sell 1 000 Doshi Dipal Common Stock
Sep 06, 2023 Sell 904 Wentworth Kory James Common Stock
Sep 06, 2023 Sell 46 Wentworth Kory James Common Stock
Sep 06, 2023 Sell 871 Kreher Nerissa Common Stock
Sep 06, 2023 Sell 21 Kreher Nerissa Common Stock
Sep 06, 2023 Sell 913 Dowden Nathan J Common Stock
Sep 06, 2023 Sell 59 Dowden Nathan J Common Stock
Sep 05, 2023 Sell 1 440 Doshi Dipal Common Stock
Sep 05, 2023 Sell 426 Wentworth Kory James Common Stock
Sep 05, 2023 Sell 449 Sethuraman Natarajan Common Stock
Sep 05, 2023 Sell 401 Kreher Nerissa Common Stock
Sep 05, 2023 Sell 436 Dowden Nathan J Common Stock
Sep 01, 2023 Buy 49 650 Doshi Dipal Common Stock
Sep 01, 2023 Buy 75 250 Doshi Dipal Stock Option (Right to Buy)
Sep 01, 2023 Buy 14 200 Wentworth Kory James Common Stock
Sep 01, 2023 Buy 21 500 Wentworth Kory James Stock Option (Right to Buy)
Sep 01, 2023 Buy 14 200 Sethuraman Natarajan Common Stock
Sep 01, 2023 Buy 21 500 Sethuraman Natarajan Stock Option (Right to Buy)
Sep 01, 2023 Buy 14 200 Kreher Nerissa Common Stock
Sep 01, 2023 Buy 21 500 Kreher Nerissa Stock Option (Right to Buy)
Sep 01, 2023 Buy 14 200 Dowden Nathan J Common Stock
Sep 01, 2023 Buy 21 500 Dowden Nathan J Stock Option (Right to Buy)
Sep 01, 2023 Buy 32 000 Chapman Gina Stock Option (Right to Buy)
Sep 01, 2023 Buy 0 Chapman Gina
Aug 14, 2023 Sell 1 000 Doshi Dipal Common Stock
Aug 04, 2023 Sell 6 898 Kreher Nerissa Stock Option (Right to Buy)
Aug 04, 2023 Buy 6 898 Kreher Nerissa Common Stock
Aug 04, 2023 Sell 6 898 Kreher Nerissa Common Stock
Aug 03, 2023 Sell 9 464 Kreher Nerissa Stock Option (Right to Buy)
Aug 03, 2023 Buy 9 464 Kreher Nerissa Common Stock
Aug 03, 2023 Sell 9 464 Kreher Nerissa Common Stock
Aug 02, 2023 Sell 10 348 Kreher Nerissa Stock Option (Right to Buy)
Aug 02, 2023 Buy 10 348 Kreher Nerissa Common Stock
Aug 02, 2023 Sell 9 280 Kreher Nerissa Common Stock
Aug 02, 2023 Sell 1 000 Kreher Nerissa Common Stock
Aug 02, 2023 Sell 68 Kreher Nerissa Common Stock
Jul 11, 2023 Sell 3 884 Wentworth Kory James Stock Option (Right to Buy)
Jul 11, 2023 Buy 3 884 Wentworth Kory James Common Stock
Jul 11, 2023 Sell 3 884 Wentworth Kory James Common Stock
Jul 11, 2023 Sell 3 897 Dowden Nathan J Common Stock
Jul 11, 2023 Sell 14 852 Sethuraman Natarajan Common Stock
Jul 10, 2023 Sell 6 116 Wentworth Kory James Stock Option (Right to Buy)
Jul 10, 2023 Buy 6 116 Wentworth Kory James Common Stock
Jul 10, 2023 Sell 6 116 Wentworth Kory James Common Stock
Jul 10, 2023 Sell 3 200 Dowden Nathan J Common Stock
Jul 10, 2023 Sell 3 026 Sethuraman Natarajan Common Stock
Jun 29, 2023 Sell 8 790 Wentworth Kory James Stock Option (Right to Buy)
Jun 29, 2023 Buy 8 790 Wentworth Kory James Common Stock
Jun 21, 2023 Sell 17 500 Wentworth Kory James Stock Option (Right to Buy)
Jun 21, 2023 Buy 17 500 Wentworth Kory James Common Stock
Jun 21, 2023 Sell 8 593 Wentworth Kory James Common Stock
Jun 21, 2023 Sell 8 907 Wentworth Kory James Common Stock
JSON CSV
INSIDER POWER
67.650
Last 100 transactions
Buy: 995 092 | Sell: 209 386 (Shares)

Based on the 100 latest insides trades, we have calculated the insider power to be positive at a ratio of 67.650.

In total, the insiders bought 995 092 and sold 209 386 TRDA shares in the last 100 trades.

Click to get the best stock tips daily for free!

About Entrada Therapeutics, Inc.

Entrada Therapeutics. Entrada Therapeutics, Inc., a biotechnology company, develops endosomal escape vehicle (EEV) therapeutics for the treatment of multiple neuromuscular diseases. Its endosomal escape vehicle platform develops a portfolio of oligonucleotide, antibody, and enzyme-based programs. The company's lead product candidate is ENTR-601-44, which is in preclinical trail for the treatment of Duchenne muscular dystrophy and myotonic dystrophy type 1. It also eng... TRDA Profile

Golden Star

Ticker Date Change Price
CVBF May 01 2.75% $16.75
FTSL May 01 0.282% $46.03
EQC Apr 30 0.694% $18.72
HRB Apr 30 0.635% $47.23
BSCQ Apr 30 0.576% $19.09
BSJP Apr 29 0.306% $22.91
LYG Apr 29 1.56% $2.56
ORA Apr 29 4.68% $64.48
DHT Apr 24 3.10% $11.28
LPLA Apr 19 3.12% $262.59
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT